Fosaprepitant 68001-0675-25
- Manufacturer
- Bluepoint Laboratories
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- October 15, 2025
- Listing Expires
- December 31, 2026
- Application
- ANDA209965
Need to source Fosaprepitant? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Fosaprepitant Dimeglumine | 150 mg/5mL |
Drug Class
Cytochrome P450 2C9 Inducers [MoA]Cytochrome P450 3A4 Inducers [MoA]Cytochrome P450 3A4 Inhibitors [MoA]
Selected Package
68001-0675-25Selected1 VIAL, SINGLE-DOSE in 1 CARTON (68001-675-25) / 5 mL in 1 VIAL, SINGLE-DOSE